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Understanding the intricacies of telomerase regulation is crucial due to the potential health
benefits of modifying its activity. Telomerase is composed of an RNA component and reverse
transcriptase. However, additional factors required during biogenesis vary between species.
Here we have identified fission yeast Lar7 as a member of the conserved LARP7 family, which
includes the Tetrahymena telomerase-binding protein p65 and human LARP7. We show that
Lar7 has conserved RNA-recognition motifs, which bind telomerase RNA to protect it from
exosomal degradation. In addition, Lar7 is required to stabilise the association of telomerase
RNA with the protective complex LSm2–8, and telomerase reverse transcriptase. Lar7
remains a component of the mature telomerase complex and is required for telomerase
localisation to the telomere. Collectively, we demonstrate that Lar7 is a crucial player in
fission yeast telomerase biogenesis, similarly to p65 in Tetrahymena, and highlight the LARP7
family as a conserved factor in telomere maintenance.
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Telomerase is an RNA-containing reverse transcriptase thatcopies new telomeric repeats onto chromosome ends andfunctions to maintain cell division1. Telomerase is
expressed in stem cells, germ cells and unicellular organisms2,3.
Conversely, most somatic cells have very low telomerase activity,
although this is reactivated in ~90% of cancers4. Telomerase
activity is therefore tightly regulated to meet the needs of the cell.
A number of premature ageing diseases, including the bone
marrow failure syndromes, dyskeratosis congenita and aplastic
anaemia, are caused by genetic mutations in genes encoding
factors involved in telomerase biogenesis and activity5. These
patients have a deficiency in telomerase activity/stability, causing
critically short telomeres. This is particularly threatening to cells
with a high turnover, such blood progenitor cells. Disease in
30–40% of these patients remains uncharacterised at the genetic
level6. Thus, it is this imperative to gain an understanding of the
telomerase biogenesis pathway.
In humans, telomerase is composed of a reverse transcriptase
(hTERT), which uses the RNA component (hTERC) to dock onto
the 3′ single-stranded telomere end. hTERT may then processively
synthesise telomeric repeats from the template provided by hTERC,
before dissociating7–9. All telomerase RNAs possess a 3′ end ele-
ment necessary for its stability10. In hTERC, this is two stem-loop
structures separated by an H-box (ANANNA) and ACA motif
(H/ACA). The binding of telomerase factors dyskerin, NOP10, and
NHP2 at the H/ACA motif form the so-called ‘pre-ribonucleo-
protein complex’, before GAR1 binds in transition to the mature
RNP11,12. hTERC then binds to chaperone TCAB1, which assists its
trafficking to the Cajal bodies where the functional telomerase
complex localises13. Recruitment to the telomeres in S-phase is
mediated by the protective complex shelterin14,15. Correct assembly
of the telomerase complex, with appropriate co-factors for
maturation, stability, and subcellular localisation, is necessary for its
function and thus telomere maintenance.
Whereas telomerase RNA is functionally conserved, the RNA
structure, maturation process, and the RNA-binding co-factors
are diverse among species16. In fission yeast Schizosaccharomyces
pombe, the telomerase RNA gene ter1+ contains an intron flanked
by two exons17,18. Following transcription, like hTERC, TER1
precursor is also polyadenylated. The 3′ end of exon 1 has a
binding site for Sm family proteins. Sm and Sm-like proteins
(LSm) are evolutionarily conserved families that function broadly
in the processing of RNA. Seven Sm proteins (SmB1, SmD1, 2
and 3, SmE, SmF and Smz) attach at this site in the poly-
adenylated TER1 in a characteristic ‘wheel’ conformation, sti-
mulating a single spliceosomal cleavage event19. However, instead
of a second cleavage followed by exon ligation, exon 1 is
released17. The Sm complex is replaced with the LSm2–8 com-
plex, during which time exonucleolytic cleavage trims the 3′-end
to expose a poly-uracil sequence19. Once the S. pombe telomerase
complex has assembled, it is recruited to the telomeres by Ccq1
and Tpz1 (equivalent to human ACD/TPP1), components of the
S. pombe shelterin complex, similarly to humans20–24. Telomerase
is then enzymatically active following stable association with the
telomere-binding proteins.
In order to examine the factors involved in regulating telomere
length homoeostasis, Liu et al.25 carried out a genome-wide
screen of deletion mutations that impacted telomere length in S.
pombe25. Deletion of 168 genes was found to alter telomere
length, with four causing ‘very short’ telomeres (>150 bp shorter
than wild type). These were est1, trt1 and ccq1, which are essential
for telomerase activity, and pof8, of unknown function. Pof8 is a
putative F-box protein, which bind to Skp1 and Cullin to form an
SCF E3 ubiquitin ligase complex26. Previous studies identified
Pof8 as a Skp1 binding protein but the association with Cullin
was not determined27,28, implying a function distinct from a
canonical F-box protein. Here we redefine Pof8 as an RNA-
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Fig. 1 lar7Δ impairs telomerase activity. a–c Telomere southern blots of genomic DNA digested with EcoRI and hybridised with a telomeric probe. a Cells
heterozygous for lar7Δ retained telomeres of wild-type length. Haploid lar7Δ cells were passaged every other day post sporulation and genomic DNA
collected at the days stated. b The trt1 and rad51 genes were deleted in wild-type and lar7Δ strains and passaged for a week. Genomic DNA was collected
and subjected to telomere southern blot. c The lar7 gene was deleted in the taz1Δ, rap1Δ and rif1Δ strains and cells were passaged for a week. Genomic
DNA was collected and subjected to telomere southern blot
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ribonucleoprotein domain family member 7 or La-related protein
7) and thus rename it Lar7. LARP7 proteins are characterised by
an N-terminal RNA-binding domain termed a La-motif and two
RNA-recognition motifs (RRMs). LARP7 proteins associate with
non-coding RNAs transcribed by RNA polymerase III, which
have a hallmark 3′-UUU-OH tag29. Here we report that Lar7
interacts with TER1 and plays a crucial role during its biogenesis.
Lar7 stabilises the interaction between TER1 and the Lsm2–8
complex and facilitates assembly with Trt1. Loss of Lar7 leads to
disassembly of telomerase and exosomal degradation of TER1,
resulting in impaired telomerase activity and maintenance of very
short telomeres. Further, we report a high degree of conservation
between Lar7 and both the human protein hLARP7 and Tetra-
hymena thermophila telomerase RNA-binding protein p65. In
human cells, loss of hLARP7 has recently been shown to cause
telomere shortening30. Thus, LARP7-familiy proteins are uni-
versally crucial for telomere maintenance.
Results
lar7Δ cells have reduced telomerase activity. To investigate the
cause of short telomeres in the absence of Lar7 (originally iden-
tified as Pof8), a haploid lar7Δ deletion strain was generated from
a heterozygous diploid parent, and passaged over generations.
Telomere lengths were measured by southern blot and found to
be considerably shorter than wild-type cells by day 5 (Fig. 1a).
Such a generation-associated shortening of telomeres suggests
loss of telomerase activity. However, critically short telomeres
were maintained over multiple generations. Following the dele-
tion of trt1+ but not rad51+, which is required for homologous
recombination, the short telomeres in lar7Δ were lost (Fig. 1b).
Thus, lar7Δ cells maintain short telomeres using telomerase and
not via an alternative pathway.
Deletion of genes encoding the telomere-associated proteins, taz1,
rap1 or rif1, leads to deregulated recruitment of telomerase and,
consequently, telomerase-dependent telomere elongation21,31,32. In
double mutants with lar7Δ, such telomere elongation was
diminished (Fig. 1c). The expression of the telomerase and shelterin
protein components that modulate telomerase activity was unaf-
fected in lar7Δ cells (Supplementary Fig. 1). Thus, shortening of
telomeres in lar7Δ cells is not due to impaired stability of telomeric
proteins, rather telomerase activity itself is reduced in the absence of
Lar7.
Lar7 is a member of the LARP7 RNA-binding protein family.
In order to assess the function of Lar7 in telomere biology, we
first analysed its predicted structure for key domains or moieties
that may allude to its function. Using the bioinformatics tool
HHpred (homology detection and structure prediction by HMM-
HMM) and the Protein Homology/Analogy Recognition Engine
v2.0 (Phyre2)33,34, we identified two likely RNA-recognition
motifs (RRMs), which have the format β1-α1-β2-β3-α2-β4, in
four fission yeast species (Supplementary Fig. 2). Additionally, we
identified structural similarity between Lar7 and the human
protein hLARP7 (La-related protein 7 or La ribonucleoprotein
domain family member 7), which is part of the wider LARP7
family of non-coding RNA-binding proteins35. Remarkably, a
well-described member of this family and orthologue of hLARP7































































Fig. 2 Lar7 is an RNA-binding protein of the LARP7 family. a Schematic representation of the predicted La-domain and RNA-recognition motifs (RRMs) in S.
pombe Lar7. Amino acid numbers of each domain are stated in brackets. Strains with the Lar7 point mutations indicated were made for further study. Lar7
is aligned with hLARP7 and p65 based on a position of each domain. b Telomere southern blot of six lar7mutant strains. Western blot (probing with α-HA)
confirms stability of each mutant protein. Original blot image is shown in Supplementary Fig. 4. Cdc2 was used to control for sample input
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All LARP-family proteins (including hLARP7 and p65) have a
conserved N-terminal La-motif followed by an RRM (together
termed the ‘La-module’) and a second RRM toward the
C-terminus (Fig. 2a). The alignment of S. pombe Lar7 with p65
and hLARP7 and a comparison of Lar7 with the published
structures of hLARP7 and p6536–38 revealed considerable
sequence and structural similarity between the three proteins
(Supplementary Fig. 3). The reported secondary structure of a
La-motif is α1-β1-α2-α3-β2-β339. According to the HHpred
analysis, the N-terminus of S. pombe Lar7 corresponds to this
predicted structure (amino acids 64–138), preceding RRM1
(amino acids 148–230). We have therefore assigned this region a
La-motif. Interestingly, the domain assigned as an F-box in Lar7
(amino acids 66–10627,28) lies within the La-motif. Due to this
striking conservation and the criteria defining LARP7 family
proteins29, in addition to the function of Lar7 in telomerase RNA
binding (defined in this report), we concluded that the annotated
Pof8 is a member of the LARP7 family and accordingly renamed
it Lar7 (La-related protein 7).
To assess whether the La-motif and the RRMs identified in
Lar7 were required for telomere maintenance, a number of
conserved residues within the domains were mutated (Fig. 2a and
Supplementary Fig. 2). Four target residues within the La-motif
were substituted to alanine. Within each RRM, two highly
conserved residues on the so-called RNP-1 consensus sequence
(β-strand 3) were identified and substituted to glutamate. Lar7
was endogenously tagged with three tandem HA epitopes and we
found that the each mutation generated in this study did not
impair stability of the Lar7 protein (Fig. 2b and Supplementary
Fig. 4). However, southern blotting in each case revealed short
telomeres; especially La-W103A, RRM1-FV197EE and RRM2-
II341EE mutations, which confer critically short telomeres, akin
to lar7 deletion. Thus, our mutagenesis analysis suggested that the
La-motif and RRMs are necessary for Lar7 function in telomere
maintenance (Fig. 2b).
Lar7 associates with TER1 and prevents exosomal degradation.
As mutations within the Lar7 RRMs caused short telomeres, we
investigated whether expression of TER1 was impaired by the loss
of Lar7. Once precursor TER1 is transcribed, spliceosomal
activity trims the product to release only exon 1, which becomes
the mature TER119. Reverse-transcriptase quantitative PCR
(qPCR) was carried out to quantify the relative amount of pre-
cursor vs. total TER1. This revealed a similar level of precursor
RNA between lar7Δ cells and wild type, but a significant reduc-
tion in the total product in the absence of Lar7 (Fig. 3a), sug-
gesting low expression of the mature form. A reduction in TER1
was also seen in the La-motif mutant W103A and the RRM
mutants FV197EE and II341EE (Fig. 3b). As the level of precursor
RNA was not reduced in lar7Δ cells, we predicted that the sta-
bility of the mature TER1 was defective.
To determine if indeed Lar7 binds to RNA, RNA-
immunoprecipitation was performed. We found that TER1
co-precipitated with Lar7 endogenously tagged with HA, with
~700-fold enrichment vs. wild-type cells with untagged Lar7
(Fig. 3c). However, the efficiency of TER1 co-precipitation was
















































































































Fig. 3 Lar7 binds and is required for accumulation of mature TER1. TER1 precursor and/or mature mRNA was quantified using RT-qPCR and normalised first
to actin and then to the expression in wild-type cells. a Positions of the primers specific to precursor (blue) and total (black) TER1 are indicated.
Significantly less total TER1 expression was detected in lar7Δ compared to wild-type (unpaired t test *** at p< 0.001). Data represented as a mean of three
independent experiments. Error bars show standard deviation. b Quantification of mature TER1 in three lar7 point-mutant strains. c Lar7 interacts with TER1
via its RNA-recognition motifs. Presence of TER1 mRNA in lysates following immunoprecipitation using α-HA was measured using reverse-transcriptase
quantitative polymerase chain reaction (RT-qPCR) and normalised first to actin mRNA and expressed as immunoprecipitated RNA over total RNA. The
efficiency of RNA precipitation in lar7mutants is represented as a percentage of enrichment relative to wild-type Lar7-3xHA. The TER1-binding protein Est1
was used as a positive control. Data is represented as a mean of two independent experiments. Error bars show standard deviation
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II341EE and the La-motif mutant W103A (Fig. 3c). Thus, the two
RRMs and the La-motif of Lar7 are required for the association
with TER1 and the interaction between Lar7 and TER1 appears to
be crucial for telomere length homoeostasis. We additionally
examined if Lar7 interacted with other non-coding RNAs,
specifically U1 and U6. We found that neither interacted with
Lar7 and loss of Lar7 did not impair their stability (Supplemen-
tary Fig. 5). This therefore suggests that Lar7 has an affinity
specifically for TER1.
In order to directly address whether loss of mature TER1 in
lar7Δ cells was associated with impaired transcription or
processing of precursor RNA, or with activation of RNA
degradation pathways, the endogenous ter1 promoter was
replaced with the nmt41 overexpression promoter. In the
presence of Lar7, the nmt41-driven expression led to an
approximately sixfold increase in total TER1 levels. However,
TER1 expression was significantly reduced in lar7Δ cells (Fig. 4a),
suggesting that TER1 is actively degraded in the absence of Lar7.
The exosome is the main pathway for RNA degradation and is
involved in RNA trimming during maturation40. The gene rrp6
encodes for a 3′-5′ exo-ribonuclease subunit of the exosome41.
The deletion of rrp6 resulted in the recovery of TER1 expression
in lar7Δ cells, close to wild-type level (Fig. 4a). A similar recovery
was observed with the nmt41 promoter-expressed TER1. Thus,
Lar7 stabilises mature TER1 by inhibiting the exosome Rrp6
activity.
We reasoned that an impaired stability of TER1 in lar7Δ cells
may be associated with the short telomere phenotype. To this
end, we analysed telomere length in the lar7Δ cells that expressed
a sufficient level of TER1 either by rrp6Δ and/or TER1
overexpression. However, despite the rescued levels of TER1,
short telomeres were still observed in cells lacking Lar7 (Fig. 4b).
Thus, TER1 is not fully functional in the absence of Lar7, even
when its degradation is prevented. This suggested that Lar7 has
another role in mediating the assembly of the functional
telomerase complex.
Lar7 is required for association of TER1 with LSm and Trt1.
The maturation of precursor TER1 RNA involves the binding of
Sm family proteins in order to initiate spliceosomal cleavage and
5′ end capping, followed by LSm2–8 binding to stabilise and
process the mature product19. We therefore investigated whether
these key steps in telomerase biogenesis were defective upon the
loss of Lar7. To test this hypothesis, we investigated the asso-
ciation of TER1 with the Sm protein Smb1, LSm component
Lsm3 and Trt1. We confirmed that the stability of Smb1, Lsm3
and Trt1 were not impaired in the lar7 mutants (Fig. 5a and
Supplementary Fig. 1). RNA-immunoprecipitation results
showed that the amount of TER1 associated with Smb1 was low
in both wild-type and lar7Δ cells (Fig. 5a). This likely reflects the
relatively transient nature of the TER1 interaction with the Sm
complex and the relatively low proportion of TER1 precursor19.
However, following Lsm3 immunoprecipitation, a dramatic
reduction of co-precipitated TER1 was observed in the absence of
Lar7 (Fig. 5a). Likewise, the level of TER1 that co-precipitated
with Trt1 was reduced to approximately 2% of wild-type levels in
lar7Δ cells. Thus, we concluded that Lar7 is required for telo-
merase assembly (Fig. 5a).
Co-immunoprecipitation assays confirmed an interaction
between Lsm3 and Lar7 (Fig. 5b), indicating that they co-exist
as a complex. Their association was sensitive to the presence of
RNase and was abolished in lar7-W103A and lar7-FV197EE
mutants. In addition, an interaction between wild-type Lar7 and
Trt1 was detected, which was also dependent on RNA (Fig. 5c).
These data suggested that Lar7, LSm2–8 and Trt1 independently
bind to TER1 to form the telomerase ribonucleoprotein complex.
Chromatin immunoprecipitation (ChIP) analysis revealed that
telomeric DNA co-purifies with Lar7, suggesting that Lar7
remains bound to TER1 and itself localises to the telomere
(Fig. 5d). Further, in lar7Δ cells, Trt1 is unable to bind at the
telomere, highlighting the need for Lar7 in telomerase assembly
and activity at the chromosome ends (Fig. 5d). Collectively, we
have demonstrated that Lar7 binding to TER1 facilitates the
association with LSm and recruitment of Trt1 to form the mature
telomerase complex.
Discussion
The structure prediction analyses we performed suggested that
the previously annotated Pof8 protein is in fact a member of the
conserved LARP7 family, which we accordingly named Lar7. Our
mutation analysis suggested that the La-motif and two RRMs of


























































































Fig. 4 lar7Δ causes exosomal degradation of TER1. a Expression of TER1 mRNA quantified using RT-qPCR and normalised to actin. Expression is shown
relative to wild-type cells without the ter1 overexpression promoter. rrp6Δ rescues the reduced expression seen in lar7Δ cells. Data represented as a mean
of four independent experiments. Error bars show standard deviation. Significantly less TER1 was detected in lar7Δ vs WT ter1 overexpression promoter
cells (p= 0.0063) and lar7Δ vs. lar7Δrrp6Δ ter1 overexpression promoter (p= 0.0242, unpaired t test * at p> 0.05 and ** at p< 0.01). b Telomere
southern blot. The rescued expression of TER1 in lar7Δrrp6Δ cells shown in a did not rescue short telomere phenotype (lanes 4 and 8)
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functional telomerase. We surmise a model in which Lar7 func-
tions in the TER1 biogenesis pathway, binding to stabilise the
interaction with the Lsm2–8 complex and facilitating assembly
with Trt1 (Fig. 5e).
We report two distinct functions of Lar7 in fission yeast: the
suppression of Rrp6-mediated degradation of TER1 and the
assembly of TER1 with LSm and Trt1 to form active telomerase.
The Lar7 orthologue, Tetrahymena p65, is required for telomer-
ase assembly as well as accumulation of telomerase RNA37,42,43.
In addition, p65 is also required for expression of the catalytic
subunit, which was not observed for fission yeast Lar7. In
humans, the data set from a study using enhanced UV-
crosslinking and immunoprecipitation (eCLIP)44 suggested a
weak or transient interaction may occur between hLARP7 and
TERC. This may serve to explain the previously reported low
telomerase activity and impaired telomere maintenance in LARP7
knockdown cells30. Thus, we believe that the LARP7-familiy
proteins have a conserved function in telomerase biogenesis, in
yeast, ciliates and potentially also in vertebrate species. As such,
hLARP7 may also be a candidate disease gene in premature
ageing syndromes such as dyskeratosis congenita.
Although the molecular mechanisms of the telomerase RNA
maturation differ between species, two structural features of the
RNA appear to be conserved: the template and pseudoknot
(T-PK) domain and the stem-terminus element (STE, or the
three-way junction domain)45,46. The telomerase catalytic subunit
binds both the pseudoknot domain and the STE domain, which is
required for its reverse-transcription activity. Tetrahymena p65
binds to the stem of the STE domain and promotes assembly of
the catalytic subunit with both the T-PK and STE domains by
facilitating a conformational change37,43. As Lar7 promotes TER1
interaction with Trt1 without directly binding it, we predict that
Lar7 also facilitates a conformational change in TER1 that pro-
motes telomerase assembly (Supplementary Fig. 6). The TER1
STE domain is essential for telomerase activity in S. pombe46,47,
and may therefore be the binding site for Lar7.
In mammals, TERC is protected from ribonuclease-dependent
degradation via the binding of the H/ACA ribonucleoprotein
complex (dyskerin, NOP10, NHP2 and GAR1). However, dyskerin
mutants that prevent telomerase activity can be rescued by stabili-
sation of TERC48, implying that, although protective, the human H/
ACA complex is not directly involved in promoting the interaction
of TERT and TERC. TCAB1 associates with the H/ACA complex
and is required for trafficking of the active telomerase to the Cajal
body and telomeres13. However, loss of TCAB1 does not impair
telomerase activity or stability of TERC. Therefore, these factors are
unlikely to be directly involved in telomerase assembly. Whether or
not hLARP7 binds TERC and promotes a conformational change to
facilitate assembly of TERT with the T-PK and STE domains
remains elusive (Supplementary Fig. 6).
Collectively, we have shown that fission yeast Lar7 is a crucial
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Fig. 5 Lar7 is required for telomerase assembly and is an integral component of the telomerase complex. a Quantification using RT-qPCR of TER1 mRNA in
lysates following immunoprecipitation using α-myc. Values were normalised first to actin and then to an untagged control. Data represented as a mean of
two independent experiments. Error bars show standard deviation. Western blot demonstrates successful expression and immunoprecipiation. Cdc2 was
used to control for sample input. b Whole-cell extracts (WCEs) were immunoprecipitated using α-myc in the presence or absence of RNase, as indicated.
Resulting immunoprecipitates were hybridised with α-myc and α-HA. Cdc2 was used as a control for sample input. c Whole-cell extracts (WCE) were
immunoprecipitated using α-HA. d Chromatin immunoprecipitation (ChIP) and qPCR to quantify telomeric DNA in lysates following immunoprecipitation
with α-myc. Data is represented as a mean of three independent experiments. Error bars show standard deviation. Lar7-Myc and Trt1-Myc precipitated
significantly more telomeric DNA vs. WT (p= 0.0327 and p= 0.0024, respectively). This was significantly abrogated in Trt1-Myc lar7Δ cells (p≤ 0.0001,
unpaired t test * at p> 0.05, ** at p< 0.01 and *** at p< 0.001). e Model indicating the role of Lar7 in stabilising the interaction between Lsm2–8 and TER1
and promoting functional telomerase assembly
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in the progression of telomerase RNA from precursor to stable
mature RNP. Our findings demonstrate that, to a degree,
assembly of the telomerase complex may be conserved between
species and LARP7 proteins are a new factor universally involved
in telomere maintenance. Considering the importance of Lar7 in
S. pombe, further investigation is required to fully elucidate the
telomeric role of hLARP7 in humans.
Methods
Media and growth condition. Fission yeast strains used for this study are listed in
Supplementary Table 1. Cells were cultured in standard rich medium (YES:
FORMEDIUM™) at 32 ˚C. For TER1 overexpression assays, cells were cultured in
synthetic minimal media (EMM: FORMEDIUM™).
Strain construction. The mutation and epitope fusion of the lar7 gene were
generated by replacement of the endogenous gene with the lar7 replacing plasmids,
pLar7c2-CheHA3. The lar7 gene including 289 bases of the upstream region was
cloned into the C-terminal tagging pNX3 vector (pNX3c2-mCherry-HA349). The
resulting plasmid was named pLar7c2-CheHA3. The cloned lar7 gene from the
plasmid was mutated using PCR-based methods and the Quickchange Lightning
site-directed mutagenesis kit (Agilent Technologies). The endogenous lar7 gene
was replaced with the kanMX6 cassette using PCR-based gene targeting method49,
to generate a strain carrying lar7::kanMX6. The lar7 plasmid was digested with
MfeI and EcoRI to generate the lar7 targeting fragment. A strain carrying the lar7::
kanMX6 allele was transformed with the digested pLar7c2 plasmid to replace the
kanMX6 cassette with the lar7-3xHA:natCX fragment using previously described
strategy50. A diploid strain carrying the lar7::kanMX6 allele was transformed with
the digested pLar7c2 plasmid. Whereas the cloned lar7 promoter region is
homologous to both allele of lar7, the terminator of the natCX cassette is only
homologous to the deleted allele with that of the kanMX6 cassette. Therefore, the
lar7-mCherry-3xHA:natCX fragment replaces the lar7::kanMX6 allele50. Expres-
sion of wild-type and mutant Pof8 in newly generated strains was confirmed by
western blot with anti-HA antibody (Supplementary Fig. 4). To express TER1 by
the thiamine repressible nmt41 promoter, a pTeb1b-Pnmt41 plasmid was gener-
ated. The ter1 gene including 299 bases of the upstream region and 429 bases of the
downstream region were cloned into pNX3b vector49. The nmt41 promoter was
inserted at the transcription start site to generate pTer1b-Pnmt41. The endogenous
ter1 gene was replaced with the TKnatAX cassette using PCR-based gene targeting
method49. The pTer1b-Pnmt41 was digested with ClaI and PmeI to generate the
Pnmt41>ter1 targeting fragment. A strain carrying the ter1::TKnatAX allele was
transformed to replace the TKnatAX cassette with the Pnmt41>ter1:hygMX6 frag-
ment. Strains carrying Trt1-9xPK and 12xPK-Est1 and other deletion mutants are
described before20. All other strains were generated by genetic crossing or PCR-
based gene targeting.
Uncropped images. Uncropped versions of the western blot and DNA gel images
presented in this manuscript can be found in Supplementary Figs. 7 and 8.
Southern blot. Southern blots to analyse telomere length were carried out on
genomic DNA prepared from strains cultured >2 weeks after generation, unless
indicated. Genomic DNA was quantified and normalised, and 40 µg digested with
EcoRI. The digested DNA fragments were separated on 1% agarose gel and
transferred by capillary action onto a nitrocellulose membrane. The membrane was
probed overnight with a hot labelled 500 base telomere probe20, before washing
and exposure to a phosphor screen for 24 h.
Protein extraction and immunoprecipitation (yeast). Logarithmically growing
cells were collected and frozen at −80 °C. Pellets were resuspended in the same
volume of HB buffer (50 mM HEPES/KOH at pH 7.5, 140 mM NaCl, 15 mM
EGTA, 15 mM MgCl2, 0.1% NP-40, 0.5 mM Na3VO4) containing protease inhi-
bitors (1 mM dithiothreitol, 1 mM PMSF, 0.1% protein inhibitor cocktail set III
(Sigma), 0.1 ng mL−1 MG132 (Sigma), 10 UmL−1 TURBO DNase (Ambion)). Cells
were broken using a Fast Prep machine (Thermo), briefly sonicated using the
Biorupter and centrifuged to collect the chromatin containing cell extract.
Monoclonal anti-Myc 9E11 (2276, Cell Signalling) and anti-HA antibodies
(901514, Covance/BioLegend) were used for pull down and detection of Myc and
HA tagged proteins, respectively. Antibodies were conjugated with mouse IgG-
coated Dynabeads (Life Technologies) overnight. Whole-cell extracts (WCEs) were
incubated with the pre-coated beads for 1 h at 4 ˚C, washed, and then resuspended
in SDS loading buffer and boiled. Samples were subjected to western blotting with
anti-HA (1:1000), anti-Myc (1:5000), or anti-PK (1:4000, anti-V5 SV5-Pk2,
MCA2892, Covance/Bio-Rad) antibodies. Anti-Cdc2 (sc-53, Santa Cruz) was used
as a control (1:5000).
Reverse-transcription quantitative PCR. RNA was collected either from loga-
rithmically growing cells or from protein lysates following immunoprecipitation
using Fungal RNA MiniPrep kit, Zymo Research. Genomic DNA was removed by
treatment with 10 UmL−1 RNase-free TURBO DNase (Ambion). RNA of 1 µg was
reverse-transcribed using 200U SuperScript IV reverse transcriptase (Thermo-
Fisher Scientific) in a 20 µL reaction using 50 µM random hexamer oligos,
according to the manufacturers guidelines. RT products were diluted to 200 µL
with DEPC treated water and RNA was removed with RNase A. Samples were
stored at −80 °C between use. RNA transcription was quantified using real-time
PCR in a 20 µL reaction with 5 µL RT product, 2× SYBR Green PCR Master Mix
(Roche) and 5 µM of each oligo, according to manufacturers guidelines. Reactions
were run on a LightCycler 480 (Roche) under the following conditions: 95 °C for
10 min followed by 40 cycles of 10 s at 95 °C, 20 s at 60 °C and 10 s at 72 °C.
Melting curve analysis was performed immediately after. Primer sets were TER1-
preF1270 5′-AATTGCGTATTTAGTAAGAACGCG-3′ and TER1preR 5′-GATT-
CATCACTTTCTCAAAATTTTGAAACCG-3′ for precursor TER1, TER1qPCRF
5′-CAGTGTACGTGAGTCTTCTGCCTT-3′ and TER1qPCRR 5′-CAAAA
ATTCGTTGTGATCTGACAAGC-3′ for whole TER1 and Act1top 5′-GGATT-
CCTACGTTGGTGATGA-3′ and Act1R277 5′-CGTTGTAGAAAGTGTG
ATGCC-3′ for actin, snU1F5 5′-ACCTGGCATGAGTTTCTGC-3′ and snU1R105
5′-GACCTT-AGCCAGTCCACAGTTA-3′ for U1, and snU6F9 5′-GATCTTCG-
GATCACTTTGGTC-3′ and snU6R151 5′-GGTTTTCTCTCAATGTCGCAG-3′
for U6. The level of TER1, U1 and U6 were normalised to actin mRNA, and TERC
and 7SK were normalised to GAPDH mRNA using the ΔCT method. All data are
expressed as ΔΔCT compared with control (wild type), unless otherwise stated.
Average was calculated from biological replicas and unpaired t test analyses were
performed to determine significance (* at p< 0.05, ** at p< 0.01 and
*** at p < 0.001).
Chromatin immunoprecipitation. Cell fixation and immunoprecipitation were
performed as previously described51. Cells were fixed in 1% formaldehyde solution
(1% formaldehyde, 0.1 mM EDTA, 0.05 mM EGTA, 10 mM NaCl, 5 mM Tris-HCl
pH8.0) for 15 minutes at 25˚C. Cells were resuspended in ice-cold ChIP-buffer1
(50 mM HEPES-KOH pH7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
Na deoxycholate). The Dynabeads conjugated anti-Myc 9E11 antibody was used
for pull down of Myc tagged Trt151. Precipitated DNA was amplified by qPCR and
enrichment of telomeric DNA was calculated after normalising to the act1 gene as
an internal control. The DNA-binding efficiency is shown relative to the value
obtained for Trt1-13xMyc or Lar7-13xMyc. Telomeric primers used for qPCR were
5′-CGGCTGACGGGTGGGGCCCAATA-3′ and 5′-GTGTGGAATTGA
GTATGGTGAA-3′.
Data availability. The authors declare that (the/all other) data supporting the
findings of this study are available within the paper (and its Supplementary
Information files) or from the authors upon reasonable request.
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